Live feed08:35:31·1267dSECFilingvia QuantisnowBrooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.BTX· BlackRock Technology and Private Equity Term TrustOriginal source
